Article
Alzheimer's Disease, Apolipoprotein E4, and Gender
4 May 1994
Abstract excerpt
<h3>To the Editor.</h3> —Researchers at Duke University have shown that apolipoprotein<i>E4</i>(apo E) gene dosage correlates with increased risk of Alzheimer's disease (AD).<sup>1</sup>Their study included members of 42 families with late-onset AD (age at onset, >60 years) with known apo E genotype and used Kaplan-Meier survival analysis to estimate the age-of-onset curves for subjects with zero, one, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
